| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 605,053 | 628,254 | 592,466 | 571,464 | | Cost of Revenue | 64,299 | 67,815 | 70,534 | 75,194 | | | Gross Profit | 540,754 | 560,439 | 521,932 | 496,270 | | | Operating Expenses | | Research Development | 181,248 | 468,568 | 160,911 | 144,862 | | Selling General and Administrative | 173,440 | 200,202 | 168,608 | 176,286 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 23,625 | 26,125 | 32,833 | 35,167 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 162,441 | (134,456) | 159,580 | 139,955 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 50,063 | 35,319 | 22,142 | 21,551 | | Earnings Before Interest And Taxes | 211,733 | (100,103) | 179,384 | 160,162 | | Interest Expense | 464 | 469 | 512 | 1,246 | | Income Before Tax | 211,269 | (100,572) | 178,872 | 158,916 | | Income Tax Expense | 48,386 | 48,690 | 42,058 | 39,033 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 162,883 | (149,262) | 136,814 | 119,883 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 162,883 | (149,262) | 136,814 | 119,883 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $162,883 | ($149,262) | $136,814 | $119,883 |
|
0.45% Nasdaq 
0.20%
Income Statement
